Literature DB >> 4113171

Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy.

R P George, J L Poth, D Gordon, S L Schrier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4113171     DOI： 10.1002/1097-0142(197206)29:6<1665::aid-cncr2820290634>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Proceedings: The effect of immunosuppression on cancer.

Authors:  I Penn; T E Starzl
Journal:  Proc Natl Cancer Conf       Date:  1972

2.  Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

3.  Affinity of antineoplastic amino acid drugs for the large neutral amino acid transporter of the blood-brain barrier.

Authors:  Y Takada; N H Greig; D T Vistica; S I Rapoport; Q R Smith
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Melphalan concentration dependent plasma protein binding in healthy humans and rats.

Authors:  N H Greig; D J Sweeney; S I Rapoport
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Treatment trade-offs in myeloma: A survey of consecutive patients about contemporary maintenance strategies.

Authors:  Brian L Burnette; Angela Dispenzieri; Shaji Kumar; Ann M Harris; Jeff A Sloan; Jon C Tilburt; Robert A Kyle; S Vincent Rajkumar
Journal:  Cancer       Date:  2013-09-19       Impact factor: 6.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.